The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
RETRACTED: Obesity and mortality of COVID-19. Meta-analysis
Open accessAbstract
Background Obesity is a global disease with at least 2.8 million people dying each year as a result of being overweight or obese according to the world health organization figures. This paper aims to explore the links between obesity and mortality in COVID-19. Methods Electronic search was made for the papers studying obesity as a risk factor for mortality following COVID-19 infection. Three authors independently selected the papers and agreed for final inclusion. The outcomes were the age, gender, body mass index, severe comorbidities, respiratory support and the critical illness related mortality in COVID-19. 572 publications were identified and 42 studies were selected including one unpublished study data. Only 14 studies were selected for quantitative analysis. Results All the primary points but the gender are significantly associated with COVID-19 mortality. The age >70, [odd ratio (OR): 0.17, CI; 95%, P-value: <0.00001], gender [OR: 0.89; CI: 95%, P-value: 0.32], BMI > 25 kg/m2 [OR: 3.68, CI: 95%, P-value: <0.003], severe comorbidities [OR: 1.84, CI:95%, P-value: <0.00001], advanced respiratory support [OR: 6.98, CI: 95%, P-value: <0.00001], and critical illness [OR: 2.03, CI: 95%, P-value: <0.00001]. Conclusions Patients with obesity are at high risk of mortality from COVID-19 infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J., Zhou, M., Wu, B., Yang, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.04.006 · Cited by 2,219
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Li, M.-Y., Li, L., Zhang, Y., & Wang, X.-S. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00662-x · Cited by 1,583
Du, R.-H., Liang, L.-R., Yang, C.-Q., Wang, W., Cao, T.-Z., Li, M., Guo, G.-Y., Du, J., Zheng, C.-L., Zhu, Q., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00524-2020 · Cited by 1,452
Dawood, F. S., Iuliano, A. D., Reed, C., Meltzer, M. I., Shay, D. K., Cheng, P.-Y., Bandaranayake, D., Breiman, R. F., Brooks, W. A., Buchy, P., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70121-4 · Cited by 1,363
Real estimates of mortality following COVID-19 infection
Baud, D., Qi, X., Nielsen-Saines, K., Musso, D., Pomar, L., & Favre, G. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30195-x · Cited by 1,253
Genotype and phenotype of COVID-19: Their roles in pathogenesis
Mousavizadeh, L., & Ghasemi, S. (2021) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2020.03.022 · Cited by 962
Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
Sattar, N., McInnes, I. B., & McMurray, J. J. V. (2020) · Circulation · doi:10.1161/circulationaha.120.047659 · Cited by 704
Impact of Obesity and Metabolic Syndrome on Immunity
Andersen, C. J., Murphy, K. E., & Fernandez, M. L. (2016) · Advances in Nutrition · doi:10.3945/an.115.010207 · Cited by 701
Obesity and its implications for covid-19 mortality
Dietz, W., & Santos‐Burgoa, C. (2020) · Obesity · doi:10.1002/oby.22818 · Cited by 687
Role of innate and adaptive immunity in obesity-associated metabolic disease
McLaughlin, T., Ackerman, S. E., Shen, L., & Engleman, E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88876 · Cited by 444
A Novel Risk Factor for a Novel Virus: Obesity and 2009 Pandemic Influenza A (H1N1)
Louie, J. K., Acosta, M., Samuel, M. C., Schechter, R., Vugia, D. J., Harriman, K., Matyas, B. T., & the California Pandemic (H1N1) Working Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq152 · Cited by 425
Risk of COVID‐19 for patients with obesity
Kassir, R. (2020) · Obesity Reviews · doi:10.1111/obr.13034 · Cited by 423
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06028-z · Cited by 421
Zheng, K. I., Gao, F., Wang, X.-B., Sun, Q.-F., Pan, K.-H., Wang, T.-Y., Ma, H.-L., Chen, Y.-P., Liu, W.-Y., George, J., et al. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154244 · Cited by 332
Commentary: Obesity: The “Achilles heel” for COVID-19?
Muscogiuri, G., Pugliese, G., Barrea, L., Savastano, S., & Colao, A. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154251 · Cited by 230
Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness.
Tanaka, S., Inoue, S., Isoda, F., Waseda, M., Ishihara, M., Yamakawa, T., Sugiyama, A., Takamura, Y., & Okuda, K. (1993) · PubMed · Cited by 205
Martins-Filho, P. R., Tavares, C. S. S., & Santos, V. S. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.043 · Cited by 181
Obesity, Acute Kidney Injury, and Mortality in Critical Illness
Danziger, J., Chen, K. P., Lee, J., Feng, M., Mark, R. G., Celi, L. A., & Mukamal, K. J. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001398 · Cited by 167
Cleemput, S., Dumon, W., Fonseca, V., Abdool Karim, W., Giovanetti, M., Alcantara, L. C., Deforche, K., & de Oliveira, T. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa145 · Cited by 164
Immunity to influenza: Impact of obesity
Rojas-Osornio, S. A., Cruz-Hernández, T. R., Drago-Serrano, M. E., & Campos‐Rodríguez, R. (2019) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2019.05.003 · Cited by 109
Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
Kang, Y.-J. (2020) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2020.60 · Cited by 81
O'Shea, D. B., Corrigan, M., Dunne, M. R., Jackson, R. W., Woods, C. P., Gaoatswe, G., Moynagh, P. N., O’Connell, J., & Hogan, A. E. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.16 · Cited by 80
Obesity, innate immunity and gut inflammation
Karagiannides, I., & Pothoulakis, C. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282c8c8d3 · Cited by 69
Houdek, M. T., Griffin, A. M., Ferguson, P. C., & Wunder, J. S. (2018) · Hand · doi:10.1177/1558944718797336 · Cited by 53
Osteoporosis in the age of COVID-19
Girgis, C. M., & Clifton-Bligh, R. J. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05413-0 · Cited by 47
Letter to the Editor: Obesity hypoventilation syndrome and severe COVID-19
Huang, J., Wang, X., Zheng, K. I., Liu, W., Chen, J., George, J., & Zheng, M. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154249 · Cited by 42
Das Fettgewebe im Fokus des Immunsystems: adipositasassoziierte Inflammation
Fischer‐Posovszky, P., & Mӧller, P. (2020) · Der Pathologe · doi:10.1007/s00292-020-00782-z · Cited by 23
El papel de la inmunidad innata en la obesidad
Fortis, Á., García-Macedo, R., Maldonado‐Bernal, C., Alarcón-Aguilar, F. J., & Cruz, M. (2012) · Salud Pública de México · doi:10.1590/s0036-36342012000200014 · Cited by 20
The obesity factor in critical illness: Between consensus and controversy
Gharib, M., KAUL, S. A., LoCurto, J., Perez, M., & Hajri, T. (2015) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000597 · Cited by 16
Cited by
Obesity in patients with COVID-19: a systematic review and meta-analysis
Huang, Y., Lu, Y., Huang, Y.-M., Wang, M., Ling, W., Sui, Y., & Zhao, H.-L. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154378 · Cited by 454
Guler, S. A., Ebner, L., Aubry-Beigelman, C., Bridevaux, P.-O., Brutsche, M., Clarenbach, C., Garzoni, C., Geiser, T. K., Lenoir, A., Mancinetti, M., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.03690-2020 · Cited by 407
Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis
Li, X., Zhong, X., Wang, Y., Zeng, X., Luo, T., & Liu, Q. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250602 · Cited by 236
Clinical review of subcutaneous semaglutide for obesity
Phillips, A., & Clements, J. N. (2022) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13574 · Cited by 49
Antunez Muiños, P. J., López Otero, D., Amat-Santos, I. J., López País, J., Aparisi, A., Cacho Antonio, C. E., Catalá, P., González Ferrero, T., Cabezón, G., Otero García, O., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-88679-6 · Cited by 27
Metadata
- Authors
- Hussain, A., Mahawar, K., Xia, Z., Yang, W., & EL-Hasani, S.
- Venue
- Obesity Research & Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 14
- Issue
- 4
- Pages
- 295-300
- ISSN
- 1871-403X (ISSN-L)
- OpenAlex
- W3040913740
- Cited by
- 373
- References
- 35
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.